Insider Buying: BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Purchases 29,795 Shares of Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 29,795 shares of the business’s stock in a transaction that occurred on Wednesday, October 16th. The shares were bought at an average price of 15.81 per share, with a total value of 471,058.95. Following the completion of the purchase, the insider now owns 20,750,913 shares in the company, valued at 328,071,934.53. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Monday, October 14th, Saba Capital Management, L.P. purchased 15,281 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.87 per share, with a total value of 242,509.47.
• On Monday, September 30th, Saba Capital Management, L.P. acquired 8,012 shares of BlackRock Health Sciences Term Trust stock. The shares were purchased at an average price of 15.84 per share, for a total transaction of 126,910.08.
• On Friday, September 27th, Saba Capital Management, L.P. bought 1,633 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 15.89 per share, with a total value of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. bought 300 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.73 per share, for a total transaction of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. purchased 2,006 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.98 per share, for a total transaction of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. acquired 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 16.14 per share, for a total transaction of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.93 per share, with a total value of 432,467.64.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ opened at 15.70 on Friday. BlackRock Health Sciences Term Trust has a 12-month low of 12.93 and a 12-month high of 16.59. The firm’s 50-day moving average price is 15.87 and its 200-day moving average price is 15.49.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be paid a $0.176 dividend. This represents a $2.11 annualized dividend and a dividend yield of 13.45%. The ex-dividend date of this dividend is Tuesday, October 15th.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Large investors have recently modified their holdings of the stock. Dakota Wealth Management lifted its position in BlackRock Health Sciences Term Trust by 5.3% in the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after buying an additional 915 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 21.7% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock worth $96,000 after acquiring an additional 1,038 shares during the last quarter. Kingswood Wealth Advisors LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 9.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock worth $360,000 after purchasing an additional 1,845 shares during the period. Comerica Bank grew its holdings in BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after purchasing an additional 3,671 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its position in BlackRock Health Sciences Term Trust by 17.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company’s stock worth $448,000 after purchasing an additional 4,604 shares during the period.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.